{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:14:27Z","timestamp":1762254867509,"version":"3.40.5"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,7]]},"abstract":"<jats:p>Hyperthyroidism is increased synthesis and secretion of thyroid hormones by the thyroid gland resulting in thyrotoxicosis. The modality of therapy for hyperthyroidism includes anti-thyroid drugs, radioiodine and surgery. Anti-thyroid drugs are the only available therapy for hyperthyroid patients in developing world as radioiodine is inaccessible and surgical set up does not exist as required. The aim of this study was to determine the magnitude and predictors of uncontrolled hyperthyroidism among hyperthyroid patients after prolonged anti-thyroid drug use. An institutional-based cross sectional study was conducted at the University of Gondar hospital, Northwest Ethiopia, between April 1, 2022 and October 31, 2022. A consecutive sampling method was used to recruit 317 study subjects. Data were collected through a pre-designed questionnaire. Patients were interviewed to obtain socio-demographic data and relevant medical information. Laboratory analyses were done based on the follow up protocol. Data were entered into EPI Info version 4.6.0.0 (EPI Info, Atlanta) and analyzed in STATA version 14 (Stata Corp LP, Texas, USA). Binary logistic regression model was used to identify variables associated with uncontrolled hyperthyroidism among hyperthyroid patients. <jats:italic toggle=\"yes\">P<\/jats:italic> value\u2005&lt;\u2005.05 was used to declare significant association. A total of 317 patients with hyperthyroidism were included in the study. The median age of the study subjects was 45 years (IQR 36\u201355 years). Most (95%) of the study participants were females. Toxic multi-nodular goiter was the most common cause of hyperthyroidism (92%), followed by toxic adenoma (5%) and Graves\u2019 disease (2%). On multivariate binary logistic regression, large goiter size (AOR: 3.163, 95% CI [1.333\u20137.506]), severe disease (AOR: 2.275, 95% CI [1.060\u20134.880]), infrequent iodinated salt intake (AOR: 3.668, 95% CI [1.245\u201310.802]), and poor adherence to anti-thyroid drug (AOR:15.724, 95% CI [5.542\u201344.610]) were statistically significant with uncontrolled hyperthyroidism at 12 months of anti-thyroid drug intake. A quarter of patients with hyperthyroidism didn\u2019t achieve euthyroid state after 12 months of anti-thyroid drug use. The identified predictors for non-euthyroid state were large goiter size, severe disease, infrequent iodinated salt intake, and poor adherence to anti-thyroid drug.<\/jats:p>","DOI":"10.1097\/md.0000000000038201","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T14:14:53Z","timestamp":1717769693000},"page":"e38201","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Control rate of hyperthyroidism and its associated factors after prolonged use of anti-thyroid drugs in a hospital setting, Northwest Ethiopia"],"prefix":"10.1097","volume":"103","author":[{"given":"Seyoum","family":"Mengesha","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3966-4969","authenticated-orcid":false,"given":"Abilo","family":"Tadesse","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biruk Mulat","family":"Worku","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kifle","family":"Alamrew","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tesfaye","family":"Yesuf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonas","family":"Gedamu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"European thyroid association guideline for the management of Graves\u2019 hyperthyroidism.","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism.","volume":"388","author":"De Leo","year":"2016","journal-title":"Lancet"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/bmb\/ldr030","article-title":"The epidemiology of thyroid disease.","volume":"99","author":"Vanderpump","year":"2011","journal-title":"Br Med Bull"},{"issue":"Suppl 2","key":"R5-20250503","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.4103\/2230-8210.83331","article-title":"Epidemiology of thyroid disease in Africa.","volume":"15","author":"Ogbera","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s43162-022-00145-5","article-title":"Thyrotoxicosis in Africa: a systematic review and meta-analysis of the clinical manifestation.","volume":"34","author":"Azeez","year":"2022","journal-title":"Egypt J Int Med"},{"key":"R7-20250503","first-page":"1","article-title":"Hyperthyroidism in a private medical service center, Addis Ababa: a 5-year experience.","volume":"58","author":"Ersumo","year":"2020","journal-title":"Ethiop Med J"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13044-019-0064-2","article-title":"Normalization of thyroid function tests among thyrotoxicosis patients attending a University Hospital in North-West Ethiopia.","volume":"12","author":"Gebreyohannes","year":"2019","journal-title":"Thyroid Res"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2147\/TCRM.S312810","article-title":"Time to euthyroidism and its determinants among thyrotoxicosis patients on anti-thyroid drug who attend to medical and ambulatory clinics of South Tigrai general hospitals.","volume":"17","author":"Maldey","year":"2021","journal-title":"Ther Clin Risk Manag"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1089\/thy.2016.0652","article-title":"Long term anti-thyroid drug treatment: a systematic review and meta-analysis.","volume":"27","author":"Azizi","year":"2017","journal-title":"Thyroid"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3803\/EnM.2021.1070","article-title":"Anti-thyroid drug treatment in Graves\u2019 disease.","volume":"36","author":"Chung","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/thy.2018.0397","article-title":"Treatment of toxic multinodular goiter: comparison of radioiodine and long-term methimazole treatment.","volume":"29","author":"Azizi","year":"2019","journal-title":"Thyroid"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3803\/EnM.2022.1476","article-title":"Efficacy and safety of long-term methimazole versus radioactive iodine in the treatment of toxic multinodular goiter.","volume":"37","author":"Azizi","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves\u2019 disease.","volume":"92","author":"Nakamura","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The role of propylthiouracil in the management of Graves\u2019 disease in adults: report of a meeting jointly sponsored by the American thyroid association and the food and drug administration.","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2009-0850","article-title":"Putting propylthiouracil in perspective.","volume":"94","author":"Cooper","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ihj.2017.07.004","article-title":"Atrial fibrillation and hyperthyroidism: a literature review.","volume":"69","author":"Reddy","year":"2017","journal-title":"Indian Heart J"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart.","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"R19-20250503","first-page":"887","article-title":"Pattern and presentation of thyro-cardiac disease among patients with hyperthyroidism attending a tertiary hospital in Ethiopia: a cross-sectional study.","volume":"21","author":"Mulatu","year":"2019","journal-title":"Ethiop J Health Sci"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archinte.1980.00330200070023","article-title":"Behavioral dysfunction in hyperthyroidism. Improvement with treatment.","volume":"140","author":"Rockey","year":"1980","journal-title":"Arch Intern Med"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/thy.2011.0334","article-title":"Diagnostic criteria, clinical features and incidence of thyroid storm based on nation wide surveys.","volume":"22","author":"Akamizu","year":"2012","journal-title":"Thyroid"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2265.2009.03682.x","article-title":"Severe hyperthyroidism: aetiology, clinical features and treatment outcome.","volume":"72","author":"Iglesias","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R23-20250503","first-page":"39","article-title":"Goitre size and outcome of medical treatment of Graves\u2019 disease.","volume":"111","author":"Laurberg","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF03343552","article-title":"Outcome of treatment of hyperthyroidism.","volume":"22","author":"Bringmann","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"3813540","DOI":"10.1155\/2017\/3813540","article-title":"Anti-thyroid drug therapy for Graves\u2019 disease and implications for recurrence.","volume":"2017","author":"Liu","year":"2017","journal-title":"Int J Endocrinol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ajcn\/77.3.663","article-title":"Thyroid size and goiter prevalence after introduction of iodized salt: a 5-y prospective study in schoolchildren in C\u00f4te d\u2019Ivoire.","volume":"77","author":"Zimmermann","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R30-20250503","first-page":"405","article-title":"The time to thyroid-stimulating hormone recovery during medical treatment in Graves\u2019 disease and autonomous hyperthyroidism.","volume":"9","author":"Martin","year":"2013","journal-title":"Acta Endocrinol"},{"key":"R31-20250503","first-page":"671","article-title":"The scope of cardiac complications of thyrotoxicosis in Lagos, Nigeria.","volume":"23","author":"Ogbera","year":"2007","journal-title":"Pak J Med Sci"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.amjms.2020.08.012","article-title":"Hypertension and hyperthyroidism: association and pathogenesis.","volume":"361","author":"Rivas","year":"2021","journal-title":"Am J Med Sci"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes.","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/439463","article-title":"Thyroid disorders and diabetes mellitus.","volume":"2011","author":"Hage","year":"2011","journal-title":"J Thyroid Res"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/EJE-13-0811","article-title":"Long-term prognosis after medical treatment of Graves\u2019 disease in a northern Swedish population 2000\u20132010.","volume":"170","author":"Mohlin","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/cen.13543","article-title":"Optimal iodine supplementation during anti-thyroid drug therapy for Graves\u2019 disease is associated with lower recurrence rates than iodine restriction.","volume":"88","author":"Huang","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF03344113","article-title":"Restriction of dietary iodine does not ameliorate the early effect of anti-thyroid drug therapy for Graves\u2019 disease in an area of excessive iodine intake.","volume":"29","author":"Hiraiwa","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/ijcp.12724","article-title":"Better adherence to antithyroid drug is associated with decreased risk of stroke in hyperthyroidism patients.","volume":"69","author":"Tsai","year":"2015","journal-title":"Int J Clin Pract"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:25:25Z","timestamp":1746318325000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":36,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038201","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}